Glaukos Corp (GKOS)
144.00
+3.17
(+2.25%)
USD |
NYSE |
Nov 22, 16:00
144.11
+0.11
(+0.08%)
After-Hours: 20:00
Glaukos Cash from Operations (Quarterly): -9.586M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -9.586M |
| June 30, 2024 | -18.37M |
| March 31, 2024 | -33.87M |
| December 31, 2023 | -10.66M |
| September 30, 2023 | -8.168M |
| June 30, 2023 | -8.161M |
| March 31, 2023 | -30.76M |
| December 31, 2022 | -4.136M |
| September 30, 2022 | -26.52M |
| June 30, 2022 | -12.21M |
| March 31, 2022 | 9.774M |
| December 31, 2021 | -4.651M |
| September 30, 2021 | 17.79M |
| June 30, 2021 | 7.391M |
| March 31, 2021 | 4.178M |
| December 31, 2020 | 10.60M |
| September 30, 2020 | -9.57M |
| June 30, 2020 | -10.92M |
| March 31, 2020 | -13.10M |
| December 31, 2019 | -4.191M |
| September 30, 2019 | -2.988M |
| June 30, 2019 | 6.602M |
| Date | Value |
|---|---|
| March 31, 2019 | 0.208M |
| December 31, 2018 | 17.13M |
| September 30, 2018 | 4.362M |
| June 30, 2018 | 3.826M |
| March 31, 2018 | -6.452M |
| December 31, 2017 | 12.46M |
| September 30, 2017 | 6.991M |
| June 30, 2017 | 4.312M |
| March 31, 2017 | 2.326M |
| December 31, 2016 | 3.278M |
| September 30, 2016 | 3.929M |
| June 30, 2016 | 6.039M |
| March 31, 2016 | -0.937M |
| December 31, 2015 | -0.57M |
| September 30, 2015 | -0.557M |
| June 30, 2015 | -0.028M |
| March 31, 2015 | -1.033M |
| December 31, 2014 | -1.49M |
| September 30, 2014 | 0.20M |
| June 30, 2014 | -1.156M |
| March 31, 2014 | -4.661M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-33.87M
Minimum
Mar 2024
17.79M
Maximum
Sep 2021
-7.757M
Average
-8.869M
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Baxter International Inc | 253.00M |
| Masimo Corp | 25.60M |
| Teleflex Inc | 230.98M |
| Perspective Therapeutics Inc | 3.366M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 30.56M |
| Cash from Financing (Quarterly) | 9.668M |
| Free Cash Flow | -81.27M |
| Free Cash Flow Per Share (Quarterly) | -0.2005 |
| Free Cash Flow to Equity (Quarterly) | -11.10M |
| Free Cash Flow to Firm (Quarterly) | -11.04M |
| Free Cash Flow Yield | -1.11% |